Atlas Trials

Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer

Clinical trial NCT00859703 · COMPLETED

Trial details

NCT number
NCT00859703
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast CancerMenopauseOsteopenia
Start date
2009-11-01
Primary completion
2013-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.